Home  /  Resource Library  /  Ofatumumab is safe and effective as front-line treatment in older patients with chronic lymphocytic leukemia and severe co-morbidities, including other malignancies

Ofatumumab is safe and effective as front-line treatment in older patients with chronic lymphocytic leukemia and severe co-morbidities, including other malignancies

Results of a study investigating ofatumumab for first line treatment of CLL in older patients with other health issues.